Related Experiment Video
Updated: Apr 18, 2026

High-throughput Screening for Protein-based Inheritance in S. cerevisiae
Published on: August 8, 2017
Yeast prions: structure, biology, and prion-handling systems
Reed B Wickner1, Frank P Shewmaker2, David A Bateman3
1Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA wickner@helix.nih.gov.
Yeast and fungal prions are infectious proteins that propagate by altering protein shape. These protein-based genes, or prions, serve as models for human amyloid diseases, offering insights into disease mechanisms and potential treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Prions are infectious proteins that transmit traits without nucleic acids.
- Yeast and fungal prions are protein-only genes, often involving altered proteins that catalyze further alterations.
- Amyloid formation, characterized by ordered β-sheet-rich aggregates, is fundamental to most yeast and fungal prions.
Purpose of the Study:
- To review the mechanisms of prion templating and biological roles.
- To explore prion interactions with cellular chaperones and aggregate-handling systems.
- To highlight yeast prions as models for understanding and treating human amyloidoses.
Main Methods:
- Review of existing literature on prion biology.
- Analysis of prion propagation mechanisms, including faithful templating of protein conformation.
- Examination of cellular factors, such as chaperones (Btn2, Cur1), involved in prion management.
Main Results:
- Prion proteins can exist in multiple self-propagating amyloid forms (prion variants) with distinct properties.
- Cellular chaperones and specific aggregate-handling systems play crucial roles in prion generation and propagation.
- Yeast prions exhibit both vertical (as genes) and horizontal (as infectious agents) transmission.
Conclusions:
- Yeast prions provide valuable models for studying mammalian amyloidoses, including human prion diseases and other amyloid-based conditions.
- Understanding prion variants in yeast may offer insights into the diverse clinical presentations of human amyloidoses.
- Research into yeast prions can inform the development of therapeutic strategies for amyloid-related diseases.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Subviral Agents
Yeast Signaling
Bioreactor Controls-III
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...

